Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 13 (5), R179
- https://doi.org/10.1186/ar3504
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 networkEuropean Journal of Pharmaceutical Sciences, 2012
- Interleukin-21 (IL-21)-mediated pathways in T cell-mediated diseaseCytokine & Growth Factor Reviews, 2009
- Interleukin 21 as a target of intervention in autoimmune diseaseAnnals Of The Rheumatic Diseases, 2008
- Interleukin-21: Basic Biology and Implications for Cancer and AutoimmunityAnnual Review of Immunology, 2008
- Blockade of the interleukin‐21/interleukin‐21 receptor pathway ameliorates disease in animal models of rheumatoid arthritisArthritis & Rheumatism, 2007
- IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine ProductionPublished by The American Association of Immunologists ,2007
- IL-21 and BAFF/BLyS Synergize in Stimulating Plasma Cell Differentiation from a Unique Population of Human Splenic Memory B CellsPublished by The American Association of Immunologists ,2007
- Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-6Published by The American Association of Immunologists ,2004
- A Critical Role for IL-21 in Regulating Immunoglobulin ProductionScience, 2002
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988